Proteomics firm Alamar Biosciences saw a significant price jump following its public debut. The company raised approximately $191 million through an upsized offering of 11.3 million shares.
- Shares climbed ~40% on Friday
- Raised approximately $191 million in gross proceeds
- Upsized offering totaled 11.3 million shares
- Opening price recorded at $22.60
- Company is based in Fremont, California
Sign up free to read the full analysis
Create a free account to unlock full AI-curated market articles, personalized alerts, and more.